Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I did not get that impression from the PR. Sounds like they will be working on products. Who knows for sure in this sector though. the wild wild west
wow CEO talks everywhere. He is extremely active promoting. Does he have time to make product? This needs contracts with names. Millions of dollars to start in contracts. Until then well same ole same ole
im waiting for the ride did I miss it?
haha you been here a long time. You know the trend is to retest near that 200mda. Kulr has not been able to hold its gains. a slow drip until next pop. If that changes great I have shares long too
would love to hear some
thanks
clueless folks or the offering?
I appreciate the tweet. I also see the long term benefit here. But why tweet something saying in the years ahead he has a goal. Market wants to know whats right in front too. Makes you think nothing is right now
oh well maybe just being cynical
Being a KULR shareholder for a while now. pattern has been clear. Pop on news then many red days to follow only to go back to where it all started
I see nothing to change that
Nice news
Canadian cannabis company Cronos purchases option to acquire 10.5% stake in PharmaCann for $110.4 million
https://finance.yahoo.com/m/49dc87fa-c5f6-3de1-84d7-d3ff6c280c9e/canadian-cannabis-company.html
Get ready
Medical
CBG
Access to American market
Another nice dividend locking up tomorrow. I even bought more shares Friday. That was sweet a dip before x divi
And the longest bull market in the history of mankind continues on.
There will be a massive spike up before any massive move down. Only possible thing could happen is a mini correction
$$$$$$$$$$$ go S & P
CBG is likely less pragmatic than CBD
https://harrisbricken.com/cannalawblog/is-cbg-legal-what-is-cbg/
I think its safe to say whatever quantities they are able to manufacture of any rare cannabinoid will be sold out completely in one form or another, in one country or another. Whether it be To a consumer through new products, wholesale , or other research firms
assuming they maintain high efficiency standards
I know one thing this plant is amazing. I have loved it for almost 50 years now : ). Its going to be fascinating what benefits are unlocked for mankind in the 100 known cannabinoids. Only way to learn is through lab production. As its the only way to produce most all of them in any quantity to further research
wow just wow I get myself excited haha
I remember all the negative posting when Google first did their IPO. I learned way back then to do my own research and listen to no one but myself. Its nice to not be affected by any message board post in anyway just take some learning from some of them
This part from the PR
By leveraging Ginkgo’s research platform and our fermentation manufacturing capabilities, we believe we have disruptive technology that can deliver rare cannabinoids at scale and elevate the consumer experience.”
I love the word disruptive. The CEO has been installed by Altria. Altria does not make claims like this unless they are darn sure. But still yet until we see it its still just potential disruptive technology
many times over my investment years I heard the words disruptive tech used in forward thinking, and it never came to be. When it does its massive
This part from the PR
Cronos Group is prioritizing rare cannabinoids, such as CBG, and plans to sequence commercial production and subsequent product launches based on this approach.
this tells me we will see production of even rarer cannabinoids than GBG soon enough
This part from the PR
Cronos Group has the exclusive right to use and commercialize certain key patented intellectual property for the use of microorganisms developed for the production of the target cannabinoids globally.
In comes Phillip Morris? We can use their distribution network and Altria gets to return the favor of being exclusive distributor for Phillip Morris
IQQS
Once again my point is they can introduce new skus. Lord Jones has introduced some new items so its already been done. No cbd is not legal in regards you can not make health claims or dietary supplement claims. You can sell it in the USA you said yourself its saturated
I agree to many cbd products you would/may be a dime a dozen, nothing special. Then again Lord Jones has done a pretty good job at differentiating themselves into an affluent client base
Altria has a unique massive distribution network as well, that's untouched. They could intro cbd products to that network. Perhaps they are waiting to add a better product one with CBG or even cbg stand alone. Just not long ago they were planning 4 new sku's to go after their network but delayed it
The world is literally their oyster if you entertain the potential of Phillip Morris being a international exclusive distribution partner. I do not see why not. Altria is an exclusive IQQS distributor for Phillip Morris in the USA
Time will tell what is up Big Tobacco's sleeve. Its evident they can be disruptive and their financial strength is unmatched especially if Altria and PM join forces
Ill take my chances with a massive position at these levels. levels well below Altria's entrance point
any further dips I will add even more!
I agree. To compete in the future they will have to sell CBG. Its clearly better than CBD. Just much more rare yet in high demand and costly
Will not be so rare soon as Cron and a couple others are now producing it in the lab. No one will compete with CBG and other rare cannabinoids you mention unless genetically produced just like we produce aspirin from the willow tree. You do not see them planting fields of willow trees for aspirin. Plus the efficacy can be what the drug companys want
https://ir.thecronosgroup.com/news-releases/news-release-details/cronos-group-and-ginkgo-bioworks-amend-agreement-accelerate
Cron is now selling CBG as of June 6th and working on developing products that have very serious disruptive potential
They can introduce new skus in the USA they have chosen not to up to this point. Remember they were going to launch a few CBD products to their distribution network and canceled it for now? They own Lord Jones will all sorts of skus. CBD and CBG is not illegal. You are just limited in the claims you can make about the product
Altria gets the disruptive products they want they can launch them worldwide in a heart beat. Imagine what the stock would do fast with the right prs
Companies will be able to grow strains of MJ that are high in CGB. However they will not nearly compete with the price of Cron/Gingkos lab grown
Plus other cannabinoids that are rare in any strain of MJ plant only lab grown can bring them to market
Cron/Altria have been moving at snail pace despite they have more money and certainly more backing then anyone. We can see why now clear as day. Once they strike the product, products that are unique and disruptive we will see the power of Altria and I believe Phillip Morris. Those two will not compete against each other
great article. Clearly CBG is better than CBD. What is even more exciting to me and there is mention of it. There are other cannabinoids in the plant virtually untouched that may be even better than CBG. Cron will be after those next and have the leading technology to be first in line
Altria also has the capability to put more money in if thats what it takes down the road a bit. PM will join in as well once they see the benefit. I look at the competition for the lab grown cannabinoids. No one has the pocket of Altria. We are in the front of the line and I expect they will strike now on a ongoing basis in many ways
Another big advantage over competition is Altria has product making experience that no one comes close to
Remember they were going to launch cbd products in the USA. Then decided to wait? I am glad they did. Their first products to their massive network should contain CBG
must admit I was wrong so far. I called sub penny a while back. Its still hanging in there. I still expect sub coming
yeah but loses were more like 10 fold. 1.7m for the Q. Thats way more than their total revenue for the year
nice volume coming in. This is a great sign
1.3m shares will not take long to go through assuming they sell 10 to 12 % per day. If our volume keeps up these will be gone soon. I really believe that incentive to hold a( 10% divi) , and proceeds from 1.3m will release the stock from financier selling pressure enabling it to move up.
Once that pressure is gone we can get to $4.00 easily
must realize the new financier got their shares the day we went to the NYSE. 1,300,000 shares were a sign on bonus. The rest were at $2.05. I expect they sell the 1,300,000. The other shares at $2.05 have a dividend attached of 10%. That is certainly an incentive to hold may of those shares. especially if they can unload the 1.3 m at good prices
We get through these and we can move IMO
You have been spot on
This is brilliant. These guys know whats going on
Just wait for that day they announce a massive name with a big deal. They may do it AH too
Amyris Inc is the other competitor in this field. Willow is small resources lower. Cron has the power of Altria. The elephant in the pack
Another big add to the team. These guys are planning on doing big business
Great consolidation going on. Kulr poised for massive gains. Well under 300 market cap currently. way to cheap
agree. plenty for everyone especially the first ones
yes it all means dilution and share selling
Looks like Amyris has a competitor in team of Ginkgos. cron .altria for CBG. Although its in high demand and rare I thin both will cash in big
Hope you all see the money that can be made with producing CBG. Watch Cron closely with Willow as these appear to be the only two companies ready to go to market
"Currently CBG is one of the most expensive cannabinoids due to the high-demand, low-supply issue. While the price may vary from supplier to supplier, the average cost appears to be about $30,000 – $50,000 per kilo."
"Versus dry flower cannabis wholesale is approx $2,300/kg US"
This is very good
This is big no doubt. Cron run by big tobacco Altria is doing the same thing but will likely be able to move faster as they have the ability to produce products through Altria
regardless these two companies Cron and CANSF are going to be disruptive
I will but this one too
here is crons news so you see they are both on same track
Cronos Group and Ginkgo Bioworks Amend Agreement to Accelerate Commercialization of Cultured Cannabinoids and Cronos Group Begins Commercial Production of CBG
https://news.yahoo.com/cronos-group-ginkgo-bioworks-amend-113000558.html
Here is an update on Willow
Willow Biosciences poised to be the first company to commercially produce CBG, the "mother of all cannabinoids"
https://www.proactiveinvestors.com/companies/news/930277/willow-biosciences-poised-to-be-the-first-company-to-commercially-produce-cbg-the--mother-of-all-cannabinoids--930277.html
here is some up to date info from their message board
Outlook
Willow completed its first commercial scale fermentation run of its first cannabinoid, CBG, in Q1 2021 with first sales expected to occur in Q2 2021. While the product volumes are expected to be small to start, this is a significant turning point in the lifecycle of the Company. During the remainder of 2021, Willow plans to optimize its commercial process for CBG, supply product to customers, seed commercial samples to larger organizations, and build out a robust order book for 2022, which the Company expects to be its first full year of commercial production and sales. CBG is a rare cannabinoid and thus Willow is at the forefront of developing that market.
JUST ANNOUNCED
Willow Biosciences and Cellular Goods Announce Multiyear Supply Agreement for Cannabigerol (CBG)
BY CANADA NEWSWIRE — 19 MINUTES AGO
VANCOUVER, BC, June 10, 2021 /CNW/ - Willow Biosciences Inc. ("Willow" or the "Company") , a biotechnology company producing ultra-pure, sustainably made compounds, and Cellular Goods PLC ("Cellular Goods") , a U.K. based provider of premium consumer products based on biosynthetically made cannabinoids, are announcing today that the two companies have signed a multi-year supply agreement, whereby Willow will supply Cellular
Here is a big company that sexpects to be the first company to biosynthetically manufacture
cannabinoids, using "a proprietary yeast strain laboratory process" to produce
commercial quantities of CBD and CBG.
Willow Biosciences Launches Two Initiatives to Support CBG Offering
Company also promotes two executives.
They were talking about this last year. The first Q of 2021 is when they are suppose to launch products. Nothing yet that I see
https://www.preparedfoods.com/articles/125017-willow-biosciences-launches-two-initiatives-to-support-cbg-offering
Perhaps Altria put their USA CBD rollout on hold because they knew CBG was coming
Why CBG and Other Rare Cannabinoids Will Supplant CBD
https://www.nasdaq.com/articles/why-cbg-and-other-rare-cannabinoids-will-supplant-cbd-2020-09-28
I recall when this ran into the upper twenties. I had bought when Altria bought in. We all thought it was heading to $50.00 or $100.00
Well it was not ready yet. Altria's plan was longer term. Now here we are. Their plan is ready for execution. People are selling it off this time. I am collecting at almost half the price I began my first go round with